Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Insulin glargine/lixisenatide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ins glargine 100u/ml / Lixis 50mcg/ml inj 3ml pf dispos dev
0601012ABAAABAB
|
Insulin glargine/lixisenatide | Insulin glargine/lixisenatide | Endocrine System | 11 |
|
Ins glargine 100u/ml / Lixis 33mcg/ml inj 3ml pf dispos dev
0601012ABAAAAAA
|
Insulin glargine/lixisenatide | Insulin glargine/lixisenatide | Endocrine System | 8 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.